TrialEuropean urology2023

Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer.

Raquibul Hannan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.